Villar-Álvarez Felipe, Martínez-García Miguel Ángel, Jiménez David, Fariñas-Guerrero Fernando, Ortiz de Lejarazu-Leonardo Raúl, López-Campos José Luis, Blanco-Aparicio Marina, Royo-Crespo Íñigo, García-Ortega Alberto, Trilla-García Antoni, Trujillo-Reyes Juan Carlos, Fernández-Prada María, Díaz-Pérez David, Laporta-Hernández Rosalía, Valenzuela Claudia, Menéndez Rosario, de la Rosa-Carrillo David
Servicio de Neumología, IIS Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, España.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España.
Open Respir Arch. 2021 Mar 22;3(2):100097. doi: 10.1016/j.opresp.2021.100097. eCollection 2021 Apr-Jun.
The Spanish Society of Pneumonology and Thoracic Surgery (SEPAR) has elaborated this document of recommendations for COVID-19 vaccination in patients with respiratory diseases aimed to help healthcare personnel make decisions about how to act in case of COVID-19 vaccination in these patients.The recommendations have been developed by a group of experts in this field after reviewing the materials published up to March 7, 2021, the information provided by different scientific societies, drug agencies and the strategies of the governmental bodies up to this date.We can conclude that COVID-19 vaccines are not only safe and effective, but also prior in vulnerable patients with chronic respiratory diseases. In addition, an active involvement of healthcare professionals, who manage these diseases, in the vaccination strategy is the key to achieve good adherence and high vaccination coverage.
西班牙肺病与胸外科学会（SEPAR）制定了这份针对患有呼吸系统疾病患者的新冠疫苗接种建议文件，旨在帮助医护人员就如何对这些患者进行新冠疫苗接种做出决策。该建议由该领域的一组专家在审查截至2021年3月7日发布的材料、不同科学协会、药品机构提供的信息以及政府机构截至该日期的策略后制定。我们可以得出结论，新冠疫苗不仅安全有效，而且对于患有慢性呼吸系统疾病的易感患者来说具有优先性。此外，管理这些疾病的医护专业人员积极参与疫苗接种策略是实现良好依从性和高疫苗接种覆盖率的关键。
